FIL Ltd Has $113.49 Million Stock Position in Amedisys, Inc. (NASDAQ:AMED)

FIL Ltd lowered its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 4.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,250,000 shares of the health services provider's stock after selling 59,623 shares during the period. FIL Ltd owned approximately 3.82% of Amedisys worth $113,488,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. lifted its holdings in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. HBW Advisory Services LLC acquired a new position in shares of Amedisys in the 4th quarter worth approximately $38,000. Versant Capital Management Inc lifted its position in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after buying an additional 183 shares during the period. Vestcor Inc acquired a new stake in Amedisys in the 4th quarter valued at $73,000. Finally, Venturi Wealth Management LLC raised its stake in Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after acquiring an additional 779 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Stephens restated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Amedisys presently has a consensus rating of "Hold" and a consensus target price of $101.00.

Remove Ads

Amedisys Trading Down 0.1 %

Shares of AMED stock traded down $0.07 during trading hours on Monday, reaching $91.44. The company had a trading volume of 10,564 shares, compared to its average volume of 400,405. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a 50 day moving average of $92.20 and a 200 day moving average of $92.01. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of 36.29, a P/E/G ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing analysts' consensus estimates of $1.05 by ($0.09). The company had revenue of $598.05 million during the quarter, compared to the consensus estimate of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. On average, equities research analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.